Plasma osteopontin in persons with HIV and the risk for cardiovascular disease
AIDS
.
2023 Feb 1;37(2):355-357.
doi: 10.1097/QAD.0000000000003445.
Authors
Sepiso K Masenga
1
,
Antonio Romanelli
2
,
Katherine W Kooij
3
4
Affiliations
1
HAND Research group, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
2
Department of Anaesthesia and Intensive Care, University Hospital 'San Giovanni di Dio e Ruggi D'Aragona', Salerno, Campania, Italy.
3
British Columbia Centre for Excellence in HIV/AIDS, Vancouver.
4
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
PMID:
36541647
DOI:
10.1097/QAD.0000000000003445
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Biomarkers
Cardiovascular Diseases* / epidemiology
HIV Infections* / complications
Humans
Osteopontin
Risk Factors
Substances
Osteopontin
Biomarkers
Associated data
ClinicalTrials.gov/NCT02874703
Grants and funding
K23 HL147799/HL/NHLBI NIH HHS/United States
P30 AI060354/AI/NIAID NIH HHS/United States
T32 MH079785/MH/NIMH NIH HHS/United States
R01 HL146267/HL/NHLBI NIH HHS/United States
R01 HL137562/HL/NHLBI NIH HHS/United States